沙利度胺治疗颅内结核瘤的临床反应：病例报告
Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report.
作者信息
de la Riva Patricia, Urtasun Miguel, Castillo-Trivino Tamara, Camino Xabier, Arruti Maialen, Mondragón Elisabet, Lopez de Munain Adolfo
机构信息
Department of Neurology, Universitary Hospital of Donostia, San Sebastian, Spain.
出版信息
Clin Neuropharmacol. 2013 Mar-Apr;36(2):70-2. doi: 10.1097/WNF.0b013e318285caa1.
PMID:23503553
Abstract
We describe a patient with multiple intracranial tuberculomas resistant to standard care with antituberculosis drugs and corticosteroids who responded well to thalidomide. Adjunctive thalidomide may have a role in the management of refractory intracranial tuberculomas, although it should be used conservatively owing to its potential adverse events.
摘要
我们描述了一名患有多发性颅内结核瘤的患者，该患者对标准的抗结核药物和皮质类固醇治疗无反应，但对沙利度胺反应良好。辅助使用沙利度胺可能在难治性颅内结核瘤的治疗中发挥作用，不过鉴于其潜在的不良事件，应谨慎使用。
Zotero 插件